Apploi Announces Partnership with CentralReach, ABA Therapy Software and Services Provider
NEW YORK, March 13, 2025 /PRNewswire/ -- Apploi, the leading workforce platform for healthcare employers, is excited to announce a...
Autism
Women’s Health Pioneer Tia Rolls Out Nabla’s AI Assistant To Enhance the Patient-Provider Relationship
Tia's mission is to help women live healthier lives by driving the highest standard of care for women by integrating...
Motivity Announces $27M Growth Investment from Five Elms Capital to Advance Innovation and Scale Operations
HONOLULU, March 12, 2025 /PRNewswire/ -- Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers...
Motivity Announces $27M Growth Investment from Five Elms Capital to Advance Innovation and Scale Operations
HONOLULU, March 12, 2025 /PRNewswire/ -- Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers...
Little Leaves Behavioral Services Expands in Maryland and Virginia
Four new ABA therapy centers will open this summer to meet growing need for high-quality, early intervention resources for young...
Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience (www.kaerusbio.com), a clinical-stage biopharmaceutical company created by Medicxi for the development...
Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH
Distribution agreements recently signed for France, Turkey, Romania and Morocco LungFit PH international distribution network now includes 18 countries Initial...
Foresight Psychology Launches Cutting Edge and Comprehensive Yet Affordable Psychological Testing Nationwide
Advanced Testing with a Reduced Wait Time SAN DIEGO, March 3, 2025 /PRNewswire/ -- Foresight Psychology, a leading provider of...
Oryzon Defines Phase III Trial Endpoints for Agitation and Aggression in BPD with Input From New Clinical Advisory Board
Leading US psychiatric experts join Oryzon’s Clinical Advisory Board (CAB) to advance Phase III development of vafidemstat in Borderline Personality...
Praxis Precision Medicines Provides Update on Essential3 and Corporate Update
BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
Guidelines for Designing Consent Materials and Procedures For Autistic Adults and People with Intellectual Disability
NEW ROCHELLE, N.Y., Feb. 27, 2025 /PRNewswire/ -- A new article in Autism and Adulthood presents guidelines for designing consent materials...
SciSparc Extends $2 Million Loan to Support AutoMax’s Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles
TEL AVIV, Israel, Feb. 27, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage...
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in...
Brighter Strides ABA Expands Services with New Clinic Opening in Maryland
Providing Compassionate, Individualized ABA Therapy for Children with AutismCatonsville, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Brighter Strides ABA is...
Lighthouse Autism Center Announces Expansion of ABA Services in Nebraska
Leading ABA Provider Set to Open Newest Location in Lincoln, NE. Therapy Room at LAC Therapy Room at LAC Therapy...
Nabla Named to the 2025 New York Digital Health 100 by Digital Health New York (DHNY)
DH100 recognizes those companies that have helped make New York the capital of healthcare innovation NEW YORK, Feb. 11, 2025...
DIGITAL celebrates continued investments in Canadian genomics
VANCOUVER, BC, Feb. 5, 2025 /CNW/ - DIGITAL, Canada's Global Innovation Cluster for digital technologies, is celebrating its ongoing impact...
SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico
TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
TeachTown’s enCORE Named Primary & Secondary Education Category Winners in the Tech & Learning Awards of Excellence: Best of 2024
WOBURN, Mass., Jan. 31, 2025 /PRNewswire/ -- TeachTown, a leading provider of special education curriculum for students with moderate to...